Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
Aging with HIV Initiative
SPNS project evaluating interventions that seek to improve the well-being of RWHAP clients 50 and older. Project period: 2022-2025.RWHAP Technical Assistance Provider updated on 02/27/2024
-
Medicare Enrollment and Coverage for Ryan White HIV/AIDS Program (RWHAP) Clients
Best practices for providing Medicare enrollment support.Resource updated 03/11/2024
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Promising Practices: The Impact of COVID-19 Related Policy Changes On Enrollment Capacity Within California's ADAP
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Community Co-Creation: Engaging Traditional and Nontraditional Partners in a National Viral Suppression Campaign
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
-
RWHAP Part B Supplemental PTR Manual
Instructions on how (RWHAP Part B Supplemental recipients can access, complete, and submit the RWHAP Part B Supplemental Program Terms Report (PTR).Resource updated 06/27/2024
-
Non-Competing Continuation RWHAP Part B/ADAP (X07): FY24 NCC Progress Report Submission
Instructions and resources for completing and submitting the FY 2024 Ryan White HIV/AIDS Program (RWHAP) Part B Non-Competing Continuation Progress Report.Resource updated 10/10/2023
-
RWHAP Program Letter: ADAPs and SUD Medications
On May 11, HRSA’s HIV/AIDS Bureau released a program letter encouraging RWHAP ADAP recipients to include medications for SUDs, including buprenorphine for OUD, and naloxone for opioid overdose prevention, on ADAP formularies.News Article updated on 05/15/2023 -
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.Resource updated 04/12/2024
-
STI Implementation Plan Released
HHS has released an implementation plan on specific actions for entities to take in preventing and treating sexually transmitted infections (STI).News Article updated on 06/13/2023 -
RWHAP Part B Supplemental Expenditures Report Manual
Instructions on how RWHAP) Part B Supplemental recipients can access, complete, and submit the RWHAP Part B Supplemental Expenditures Report.Resource updated 06/27/2024
-
Aplicación de Estrategias de Conocimiento en Salud para Fomentar la Participación de Personas con VIH en Cuidados y Planificación Comunitaria
Propósito
El propósito de este webinar es explorar la efectiva utilización de estrategias de conocimiento en salud para promover y aumentar la participación de personas con VIH en actividades de atención médica y planificación comunitaria. Los participantes obtendrán conocimientos prácticos sobre cómo aprovechar el conocimiento en salud para fomentar una participación activa.
Objetivos de Aprendizaje
Al final del webinar, los participantes serán capaces de:
Event updated 10/23/2023
-
Recap: Success Stories in the 2023 RWHAP Biennial Report
Way back in September, the document often referred to as the biennial Ryan White report was released by HRSA's HIV/AIDS Bureau (HAB).News Article updated on 11/01/2023 -
Enlaces Por La Salud
Enlaces Por La Salud is an HIV linkage, navigation, and education program for Mexican men and transgender women. The intervention is grounded in a transnational framework for providing cultural context to support the delivery of one-on-one educational sessions to Latina(o/x) people with a new HIV diagnosis, as well as people with HIV who are not yet retained in care. After 12 months, the majority of people participating in Enlaces Por La Salud were retained in care and reached viral suppression.Resource from the RWHAP Best Practices Compilation updated on 06/26/2024
-
Virginia Rapid Start Collaborative
Virginia Rapid Start launched with HIV care providers across the state with goals to initiate ART for clients within 14 days of HIV diagnosis and to improve access to, and retention in, high-quality HIV care and support services. Through Virginia Rapid Start, providers initiated ART medications within an average of four days of HIV diagnosis, as compared with the statewide average of 28 days. Virginia Rapid Start clients had higher rates of viral suppression compared to both the RWHAP Part B overall and Virginia overall. The success of Virginia Rapid Start led VDH to expand the program to the entire Virginia RWHAP Part B.Resource from the RWHAP Best Practices Compilation updated on 01/18/2024
-
Funding Opportunity: RWHAP Implementation for HIV Clinical Quality Improvement (HRSA-24-072)
This HRSA HIV/AIDS Bureau pre-application webinar was for the Notice of Funding Opportunity, Ryan White HIV/AIDS Program (RWHAP) Implementation for HIV Clinical Quality Improvement (HRSA-24-072).Resource updated 01/29/2024